Metoprolol Tartate 1mg | 5mL Injectable SDV

Product Overview:

Metoprolol Tartrate 1mg/mL Injectable SDV (Single-Dose Vial) is a sterile, non-pyrogenic solution intended for intravenous administration in clinical settings. Metoprolol Tartrate is a selective beta1-adrenergic receptor blocker used primarily for managing various cardiovascular conditions, including hypertension, acute myocardial infarction, and tachyarrhythmias. This injectable form is particularly useful in situations where rapid control of heart rate and blood pressure is necessary.

Key Features:

1. Concentration and Volume:

• Each vial contains 5mL of solution with a concentration of 1mg of metoprolol tartrate per milliliter, ensuring precise dosing for intravenous administration.

• Metoprolol Tartrate selectively blocks beta1-adrenergic receptors, reducing heart rate, cardiac output, and blood pressure. It is particularly effective in reducing myocardial oxygen demand, making it a key treatment option in acute cardiac conditions.

• When administered intravenously, metoprolol tartrate acts rapidly, which is essential for acute management of conditions such as supraventricular tachycardia or hypertension in emergency settings.

• The solution is manufactured to be sterile and free from pyrogens, ensuring it is safe for intravenous use and reducing the risk of infection or adverse reactions.

• Packaged in a single-dose vial, this product is intended for one-time use, minimizing the risk of contamination and ensuring the sterility of each dose.

Indications: Metoprolol Tartrate 1mg/mL Injectable SDV is indicated for:

• The treatment of hemodynamically stable patients with definite or suspected acute myocardial infarction to reduce cardiovascular mortality.
• The management of hypertension, particularly in situations where rapid blood pressure control is necessary.
• The control of tachyarrhythmias, such as atrial fibrillation or supraventricular tachycardia.

Contraindications and Precautions:

• Contraindications: Known hypersensitivity to metoprolol or any of the excipients. It should not be used in patients with severe bradycardia, heart block greater than first degree, cardiogenic shock, or overt cardiac failure.
• Precautions: Use with caution in patients with bronchospastic diseases, diabetes mellitus, or severe hepatic impairment. Monitor blood pressure, heart rate, and electrocardiogram (ECG) regularly during administration.

Side Effects: Potential side effects may include, but are not limited to:

• Bradycardia (slow heart rate)
• Hypotension (low blood pressure)
• Dizziness or fatigue
• Bronchospasm in susceptible individuals
• Heart failure in patients with compromised cardiac function

Storage and Handling:

• Store at controlled room temperature, protected from light.
• Do not freeze. Discard any unused portion after opening, as it is intended for single use only.